The latest price target for Omega Healthcare Invts (NYSE:OHI) was reported by JMP Securities on February 7, 2025. The analyst firm set a price target for $0.00 expecting OHI to fall to within 12 months (a possible -100.00% downside). 15 analyst firms have reported ratings in the last year.

The latest analyst rating for Omega Healthcare Invts (NYSE:OHI) was provided by JMP Securities, and Omega Healthcare Invts reiterated their market perform rating.

The last upgrade for Omega Healthcare Investors Inc happened on December 9, 2024 when BMO Capital raised their price target to $45. BMO Capital previously had a market perform for Omega Healthcare Investors Inc.

The last downgrade for Omega Healthcare Investors Inc happened on January 16, 2024 when B of A Securities changed their price target from $33 to $31 for Omega Healthcare Investors Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Healthcare Invts, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Healthcare Invts was filed on February 7, 2025 so you should expect the next rating to be made available sometime around February 7, 2026.

While ratings are subjective and will change, the latest Omega Healthcare Invts (OHI) rating was a reiterated with a price target of $0.00 to $0.00. The current price Omega Healthcare Invts (OHI) is trading at is $35.60, which is out of the analyst’s predicted range.